Yunnan Botanee Bio-Technology Group Co Ltd (300957): Kapitalflussrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 30,97 Renminbi Yuan | 48,982 Renminbi Yuan | 29,48 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 41,276 Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 423.600.000 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
Umsatz | 5.358.638,785 | 5.735.865,254 | 5.727.305,245 | 5.013.873,728 | 4.022.403,431 | 2.636.488,347 | 1.943.745,54 | 1.240.490,198 | 798.044,165 |
Cashflow aus operativer Geschäftstätigkeit | 976.595,74 | 694.865,456 | 610.438,763 | 769.445,621 | 1.152.720,351 | 431.026,329 | 514.923,171 | 102.196,796 | 202.442,521 |
▸ Operative Cashflow Marge | 18,22% | 12,11% | 10,66% | 15,35% | 28,66% | 16,35% | 26,49% | 8,24% | 25,37% |
Investitionsausgaben (CapEx) | 482.989,26 | 378.384,831 | 274.275,485 | 353.420,863 | 270.683,721 | 89.452,878 | 61.011,436 | 31.558,885 | 13.617,08 |
Cashflow aus Investitionstätigkeit | - | -1.083.933,403 | -518.055 | -18.485,43 | -2.558.476,992 | -86.320,188 | -60.859,005 | -28.723,359 | -13.612,113 |
Cashflow aus Finanzierungstätigkeit | - | 52.472,335 | -458.470,048 | -319.663,979 | 2.664.240,363 | -121.047,255 | -177.977,901 | -85.249,365 | -51.147,78 |
Freier Cashflow | 493.606,48 | 316.480,625 | 336.163,278 | 416.024,758 | 882.036,63 | 341.573,451 | 453.911,735 | 70.637,911 | 188.825,441 |
▸ Freie Cashflow Marge | 9,21% | 5,52% | 5,87% | 8,3% | 21,93% | 12,96% | 23,35% | 5,69% | 23,66% |
Ausgeschüttete Dividenden | -265.638,494 | -262.516,132 | -339.139,87 | -55.460,049 | -190.620 | -100.800 | -190.805,688 | -37.369,36 | -1.375 |
Neuausgabe und Rückkäufe von Stammaktien | - | -124.879,321 | -109.838,205 | - | -2.862.439,783 | - | -14.787,8 | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.